Lavipharm’s financial figures were presented by the Group’s CFO Vasilis Baloumis, during the annual analyst briefing at the Athens Stock Exchange. The figures reflect dynamic growth despite the challenging macroeconomic…
Lavipharm: Focus on the development, production and sale of pharmaceutical products – Η ΝΑΥΤΕΜΠΟΡΙΚΗ